We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin.
- Authors
Chie Yanagisawa; Hideaki Hanaki; Taiji Natae; Keisuke Sunakawa
- Abstract
Abstract Human-origin intravenous immunoglobulin (IVIG) collected from healthy individuals was tested for its neutralizing activity against the hemolysin, toxic shock syndrome toxin-1 (TSST-1), and enterotoxins, produced by laboratory strains of methicillin-resistant Staphylococcus aureus (MRSA). The hemolytic activity of the culture supernatant against sheep red blood cells was reduced from 100% to 5.5% relative hemolysis in the presence of 0.156 mg protein/ml of IVIG. The maximum dilution endpoint of the culture supernatant for TSST-1-mediated latex aggregation was 32-fold. This level of TSST-1 activity was reduced to eightfold dilution by 0.78 mg protein/ml of IVIG, and the latex aggregation activity of undiluted TSST-1 in the culture supernatant was inhibited by 1.56 mg protein/ml of IVIG. Similarly, the enterotoxin A-mediated latex aggregation titer appeared to be a 320-fold dilution. This toxin activity was reduced to an 80-fold dilution and below a tenfold dilution by 0.049 through 0.78 and 1.56 mg protein/ml, respectively, of IVIG. These results show that IVIG has powerful neutralizing activity against hemolysin, TSST-1, and enterotoxin A. Therefore, IVIG may be useful for passive immunization therapy in patients suffering from diseases caused by MRSA exotoxins.
- Subjects
IMMUNOGLOBULINS; STAPHYLOCOCCUS aureus; HEMOLYSIS &; hemolysins; TOXIC shock syndrome; ENTEROTOXINS
- Publication
Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2007, Vol 13, Issue 6, p368
- ISSN
1341-321X
- Publication type
Article
- DOI
10.1007/s10156-007-0551-6